NCT06247202

Brief Summary

The aim of this study is to investigate the effect of mobile health nutrition education intervention in the changing of dietary habits and body composition of overweight and obese 8-12 years old children in Sharjah, United Arab Emirates and to compare its effectiveness to paper educational intervention among the same age group. The main questions it aims to answer are:

  1. 1.Are there any significant changes in dietary habits, physical activity and body composition among overweight and obese school-age children after three months of mobile health intervention?
  2. 2.Is there any significant difference between the effect of smart phone delivered and paper delivered interventions (changes in dietary habits, physical activity and body composition) among overweight and obese school-age children after three months of interventions?
  3. 3.Are there any significant changes in the obesity inflammatory panel among overweight and obese school-age children after three months of mobile health intervention?
  4. 4.Is there any significant difference in the sustainability of the outcomes between mobile health and paper delivered interventions among overweight and obese school-age children two months after the end of the intervention?
  5. 5.Are there any significant changes in nutrition related knowledge among parents of overweight and obese school-age children after three months of intervention?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 7, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 7, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2024

Completed
Last Updated

May 14, 2024

Status Verified

May 1, 2024

Enrollment Period

3 months

First QC Date

January 7, 2024

Last Update Submit

May 11, 2024

Conditions

Outcome Measures

Primary Outcomes (19)

  • Weight

    Will be measured using a Body Composition Analyzer, and will be measured in Kilograms

    3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  • Height

    Will be measured using a standing Stadiometer, and will be measured in Centimetres

    3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  • Body Mass Index

    Will be calculated using the weight and height, and will be measured in kg/m\^2

    3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  • Body Fat Mass

    Will be measured using a Body Composition Analyzer, and will be measured in Kilograms

    3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  • Fat Free Mass

    Will be measured using a Body Composition Analyzer, and will be measured in Kilograms

    3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  • Total Body Water

    Will be measured using a Body Composition Analyzer, and will be measured in Kilograms

    3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  • Parents' Knowledge

    Using a valid Nutrition Knowledge Attitude Practice Questionnaire - no scale

    twice: before intervention (at 0 months) and after intervention (at 3 months).

  • Children's Dietary Intake

    Using 24 Hours' Diet recall (3 days).

    3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  • Children's Physical Activity

    Using a valid Physical Activity Questionnaire - no scale

    3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  • Salivary C-Reactive Protein Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    twice: before intervention (at 0 months) and after intervention (at 3 months).

  • Salivary Adiponectin (Acrp30) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    twice: before intervention (at 0 months) and after intervention (at 3 months).

  • Salivary Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    twice: before intervention (at 0 months) and after intervention (at 3 months).

  • Salivary Complement Factor D (Adipsin) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    twice: before intervention (at 0 months) and after intervention (at 3 months).

  • Salivary Interleukin 6 (IL-6) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    twice: before intervention (at 0 months) and after intervention (at 3 months).

  • Salivary Interleukin 10 (IL-10) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    twice: before intervention (at 0 months) and after intervention (at 3 months).

  • Salivary Leptin (OB) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    twice: before intervention (at 0 months) and after intervention (at 3 months).

  • Salivary Resistin Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    twice: before intervention (at 0 months) and after intervention (at 3 months).

  • Salivary Plasminogen Activator Inhibitor-1 (Serpin E1 / PAI-1) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    twice: before intervention (at 0 months) and after intervention (at 3 months).

  • Salivary Tumour Necrosis Factor alpha (TNF alpha) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    twice: before intervention (at 0 months) and after intervention (at 3 months).

Study Arms (2)

Intervention group

EXPERIMENTAL

Participants in the intervention group will receive smart phone delivered health education in the form of text messages through WhatsApp.

Other: Smart Phone Education (mhealth)

Control group

ACTIVE COMPARATOR

Participants in the control group will receive paper delivered health education in the form of a one time handout.

Other: Paper Education (conventional)

Interventions

Nutrition and Health Education module delivered through m-health approach (smart phones)

Intervention group

Nutrition and Health Education module delivered through conventional approach (paper)

Control group

Eligibility Criteria

Age8 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Overweight/obese children (over 2 SD based on the WHO Growth Reference (2007)).
  • Between 8 - 12 years old.
  • Attending school in Sharjah, UAE.

You may not qualify if:

  • Children on a specific diet.
  • Children who have any chronic diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Sharjah

Sharjah city, United Arab Emirates

Location

MeSH Terms

Conditions

Pediatric Obesity

Interventions

TelemedicineCongresses as Topic

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services AdministrationOrganizationsHealth Care Economics and Organizations

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Lab technician who will handle the saliva analysis and the person who will be doing the statistical analysis will be blinded of any data related to the grouping of the participants.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly divided into intervention group and control group. intervention group will receive smart phone delivered nutrition education while control group will receive paper delivered nutrition education.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 7, 2024

First Posted

February 7, 2024

Study Start

December 1, 2023

Primary Completion

March 10, 2024

Study Completion

May 10, 2024

Last Updated

May 14, 2024

Record last verified: 2024-05

Locations